Events

Matthew Herder and colleagues critically analyze the basis upon which Health Canada approved OxyContin.

In this posted letter, Matthew Herder explains his reasons for resigning from the Patented Prices Review Board on Mon. 20 Feb 2023.

Matthew Herder and colleagues critically review the regulatory history of buprenorphine formulations in Canada.

Matthew Herder and colleagues publish on the topic of fair pricing and Canada's orphan drug policy.

Françoise Baylis is interviewed by "Podcast or Perish" host Cameron Graham about her work generally, and on the ethics of gene editing specifically.

IDEAS speaks to world-leading bioethicist Françoise Baylis, a recent winner of the 2022 Canada Council Killam Prize for her influential work.